logo
episode-header-image
Jan 2024
5m 53s

Exploring the Potential of Therapeutic P...

Eddy Joe Gutierrez, MD
About this episode
tail spinning
Up next
Apr 8
Albumin in Critically Ill Patients: Evidence, Indications, and the 5% vs 25% Debate
Albumin is one of those topics where everyone has an opinion, but very few people actually look at the cost-benefit data. In this lecture, I’m breaking down why the 5% albumin you’re hanging might be a waste of money, and where the 25% concentration actually moves the needle in s ... Show More
30m 5s
Nov 2025
Peripheral Vasopressors, Practically Safe: What a 250-Patient Prospective Cohort Means for Your Unit
A new prospective multicenter cohort of 250 patients with shock examines the safety and outcomes of peripheral vasopressor administration. Extravasation events were rare and clustered only after several days of infusion, while norepinephrine use and simple physiologic markers cor ... Show More
7m 32s
Nov 2025
CCBs and Oxygenation: Why the Sat Falls After the Drip
Intravenous dihydropyridine calcium channel blockers can quietly worsen oxygenation by blunting hypoxic pulmonary vasoconstriction. In this episode, we break down the bedside mechanism, which agents are implicated, who’s at highest risk (post-op atelectasis, obesity, pneumonia, f ... Show More
7m 46s
Recommended Episodes
Jul 2025
Epidemiology and Outcomes in HFimpEF | JACC Deep Dive
In this JACC Deep Dive, Editor-in-Chief Harlan M. Krumholz, MD, SM, discusses a large real-world study by Min et al. examining heart failure with improved ejection fraction (HFimpEF) in over 24,000 patients. The study found that while EF improvement is common (30%), true remissio ... Show More
8m 31s
Aug 2024
Ep. 58 Regenerative Medicine meets Regenerative Physio with Dr. Tom Buchheit
<p> Join Dr. Jerry Yoo as he sits down with Dr. Tom Buchheit, Director of the Regenerative Pain Therapies Program at Duke University. In this episode, Dr. Buchheit shares insights into how regenerative medicine and regenerative physical therapy can potentially spare individuals f ... Show More
49m 37s
Jul 2023
Prof. John Myburgh talks Fluids, Catecholamines, South Africa and a little bit of Research.
In this episode, we have the honor of speaking with Professor John Myburgh, a former South African physician and researcher who has dedicated his life to improving the field of critical care medicine. Professor Myburgh has made significant contributions to the field of fluid resu ... Show More
33m 24s
Sep 2025
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ... Show More
24m 38s
Mar 2024
Episode 19: Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
Episode 19 is the third episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu and Dr. Claudio Ronco (International Renal Research Institute of San Borto ... Show More
11 m
Feb 2025
The Highs and Lows of Treating Osteoporosis in Dialysis Patients
Osteoporosis in dialysis patients is a challenging yet crucial aspect of kidney care, often overshadowed by more familiar concerns. This episode of Life as a Nephrology Professional brings together experts to uncover the unique dynamics of bone disease in end-stage kidney disease ... Show More
46m 5s
Jul 2024
Ethical Considerations in CAR T-cell Therapy
Welcome to a thought-provoking episode of our podcast series, where we dive into the ethical and practical challenges of CAR T-cell therapy with Professor Marie José Kersten from Amsterdam University Medical Centers.In this episode, our host Dr Isabel Olivera engages in a deep di ... Show More
21m 56s
Oct 2025
Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ... Show More
1 h
Oct 2024
Hemophilia Part 2
In the next podcast episode, we will continue our talk on hemophilia. Specifically the treatment of hemophilia. We'll discuss the different types of therapy available, from traditional factor replacement to emerging gene-techniques. Join Dr. Niket Sonpal as he helps us manage hem ... Show More
9m 17s
Jun 2025
Episode 124: Inside the Chest: NodeAI and the Future of Endobronchial Ultrasound
<p>In this episode, we sit down with Dr. Wael Hanna, thoracic surgeon and founder of NodeAI, a pioneering startup transforming the evaluation of mediastinal lymph nodes through artificial intelligence. Dr. Hanna shares the inspiration behind NodeAI, the clinical problem it aims t ... Show More
19m 48s